Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-31
1998-12-15
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142368, 514269, 514307, 514326, 514340, 514365, 514378, 514379, 514380, 544 60, 544111, 544137, 544140, 544297, 544298, 544322, 544333, 546141, 546143, 546209, 546275, 548146, 548240, 548245, 548248, C07D26102, C07D21700, A61K 3154, A61K 31445
Patent
active
058497366
ABSTRACT:
This invention relates to novel isoxazolines and isoxazoles which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex or the vitronectin receptor, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
REFERENCES:
patent: 4267186 (1981-05-01), Knops et al.
patent: 4283544 (1981-08-01), Jautelat et al.
patent: 4358598 (1982-11-01), Jautelat et al.
patent: 5039805 (1991-08-01), Alig et al.
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5276049 (1994-01-01), Himmelsbach et al.
patent: 5281585 (1994-01-01), Himmelsbach et al.
patent: 5294616 (1994-03-01), Duggan et al.
patent: 5334596 (1994-08-01), Hartman et al.
patent: 5397796 (1995-03-01), Zoller et al.
patent: 5424293 (1995-06-01), Zoller et al.
patent: 5446056 (1995-08-01), Wityak et al.
patent: 5455243 (1995-10-01), Duggan et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5478945 (1995-12-01), Sato et al.
patent: 5489693 (1996-02-01), Linz et al.
patent: 5559127 (1996-09-01), Hartman et al.
Phillips et al.., Cell (1991) 65, pp. 359-362.
Hartman et al.., J. Med. Chem. (1992) 35, pp. 4640-4642.
Alig et al.., J. Med. Chem. (1992) 35, pp. 4393-4407.
Askew et al.., Bioorg. Med. Chem. Lett. (1995) 5, p. 475.
Batt Douglas Guy
Cain Gary Avonn
DeGrado William Frank
Hussain Munir Alwan
Mousa Shaker Ahmed
Ferguson Blair Q.
Rotman Alan L.
The DuPont Merck Pharmaceutical Company
LandOfFree
Isoxazoline and isoxazole fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazoline and isoxazole fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazoline and isoxazole fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1458130